(Total Views: 362)
Posted On: 07/05/2018 5:04:49 PM
Post# of 72440
Saw the reference below elsewhere.....seems like B-OM is first up in terms of a licensing agreement.....I wonder if it is Lilly since they have a Head and Neck chemo drug that has OM as a side effect? Also curious as to how BTD would impact this. If P results are good and we have a licensing agreement for B-OM with BTD thrown in....wow.... and all before 9/30!
(c) “BD Agreement” means a significant licensing arrangement with a pharmaceutical company that will include an initial (“up-front”) payment to the Company in an amount in the double-digits millions of dollars and will arrange for such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA.
(c) “BD Agreement” means a significant licensing arrangement with a pharmaceutical company that will include an initial (“up-front”) payment to the Company in an amount in the double-digits millions of dollars and will arrange for such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA.
(2)
(0)Scroll down for more posts ▼
